Skip to main content

FDA Launches New Website to Encourage COVID-19 Rehabilitation Patients to Donate Plasma

According to foreign media TechCrunch, one of the ways currently being sought to develop effective treatments for COVID-19 is to use convalescent plasma. Basically, this means using plasma from COVID-19 patients who have fully recovered, hoping to transfer the antibodies they produced during the fight against the virus to others. 

US Food and Drug Administration (FDA) creates dedicated website to seek recovery plasma donations

The US Food and Drug Administration (FDA) has created a dedicated new website that seeks recovery plasma donations from COVID-19 rehabilitation patients and explains their potential uses.

The use of plasma during recovery is hardly a new concept. In fact, it has been used since the late 1890s and was used during the Spanish influenza pandemic in 1918, although "the results were mixed."

Modern methods can help improve the efficacy and potential of recovered plasma as a therapeutic method. There are currently some drugs under development that use plasma (animals and humans) as the basic active ingredients of their methods.
COVID-19 Rehabilitation Patients to donate plasma

The new FDA website around COVID-19 plasma donation defines what it is and why it is a possible treatment. It also outlines the conditions that an individual needs to meet in order to be eligible for donation (when there are no symptoms for at least 28 days before donation, or at least 14 days when combined with laboratory-confirmed COVID-19 viral plasma). Also, guides people through the American Red Cross Or donate at a nearby local blood center.

Since plasma therapy in the recovery phase is still used as a potential therapy, why do we need so many COVID-19 patient plasma? 

This is mainly because there is a lot of work underway to determine whether it can really help fight the virus, including clinical trials of several different treatments, and the one-time approved through the FDA’s emergency investigational new drug (eIND) program Single disease treatment authorization.

As with every potential treatment and vaccine being developed at this stage, convalescence plasma therapies have not yet been proven, and efforts currently underway to study its effectiveness are unlikely to be in one way or another in the short term To prove its effectiveness. Nonetheless, the demand for plasma supply is still growing to help drive this work, so the FDA decided to encourage more donations through specialized information resources like this.



See Also: 




    Comments

    Popular posts from this blog

    Difference Between COVID-19 Coronavirus and Other Flu Epidemic Infections

    What are the differences between COVID-19 and the flu epidemic?The epidemic caused by the new Coronavirus (2019-nCoV) is still spreading. This disease, which has just been officially named COVID-19, has caused more than 40,000 infections and more than 1,000 deaths. At the same time, on the other side of the ocean, another epidemic also attracted people's attention. The flu season in the United States is on schedule. 
    According to data released by the US Centers for Disease Control and Prevention, as of February 1, 22 million to 31 million people are expected to be infected during the flu season, and the number of patients dying from influenza is between 12,000 and 30,000. 
    Seeing such figures, some readers may be surprised when they think: Is the flu epidemic in the United States worse? What are the differences between COVID-19 and the flu epidemic? Is this really the case? What are the differences between COVID-19 and the flu epidemic?
    The facts are being unraveled below: 1. Unknown ris…

    Physiological and Pathological Mosquitoe Floaters

    What are the differences between physiological floaters and pathological floaters?What are the differences between physiological and pathological flying mosquitoes after the birth of a child? What are the differences between physiological and pathological flying mosquitoes? Experts believe everyone can guess literally. It is true that this is an ophthalmological disease. People with flying mosquitoes will have dark shadows shaking in front of their eyes when they are looking at things, and the vision is not clear, and flying mosquitoes can beFlying Mosquitoes
    Mentioned flying mosquitoes, I believe everyone can literally guess that this is an ophthalmic disease, the fact is true. Patients with flying mosquitoes will have black shadows swaying in front of their eyes when watching things, and the vision is unclear.
    Flying mosquitoes can be divided into physiological and pathological types. Below I will introduce you to physiological flying mosquitoes and The difference between pathologica…